Herbs (Global Traditional) · Pacific Islands
Zingiber zerumbet (Shampoo Ginger)
Moderate Evidencebotanical4 PubMed Studies
Hermetica Superfood Encyclopedia
Zingiber zerumbet contains zerumbone, a sesquiterpenoid that exhibits anti-inflammatory and antimicrobial properties through nuclear factor-kappa B (NF-κB) pathway inhibition. The plant's phenolic compounds and flavonoids like kaempferol provide additional antioxidant activity against oxidative stress.
Zingiber zerumbet, commonly known as shampoo ginger or awapuhi, is a perennial herbaceous plant native to Southeast Asia (India, Indonesia, Malaysia) and widely cultivated in tropical regions like Hawaii. The plant's rhizomes are rich in bioactive compounds, while its inflorescences produce a mucilaginous exudate traditionally used as natural shampoo, with extracts typically obtained via ethanol or water solvent methods.
No human clinical trials, randomized controlled trials, or meta-analyses for Zingiber zerumbet were identified in the research sources. All evidence comes from preclinical in vitro and traditional use data, with recommendations for rigorous human trials needed for validation.
No clinically studied dosage ranges are available due to absence of human trials. Patent formulations for topical shampoo use suggest 0.5-10% Zingiber zerumbet extract by weight, but this lacks clinical validation and standardization. Consult a healthcare provider before starting any new supplement.
Zingiber zerumbet (Shampoo Ginger) rhizome contains moderate carbohydrates (~60-70% dry weight as starch), low protein (~3-5% dry weight), and minimal fat (~1-2% dry weight. Key bioactive compounds include zerumbone (primary sesquiterpene, ~0.5-2% of essential oil by weight), a monocyclic sesquiterpene ketone that drives anti-inflammatory and antimicrobial activity. Phenolic compounds include kaempferol and quercetin (flavonoids, ~0.1-0.5 mg/g dry weight combined), contributing antioxidant capacity. Saponins are present at ~1-3% dry weight, responsible for surfactant/cleansing properties. The essential oil fraction (~0.5-1.5% fresh rhizome weight) also contains camphene, α-pinene, and humulene as minor sesquiterpenes. Mineral content includes modest potassium (~300-400 mg/100g fresh), calcium, and magnesium. Bioavailability notes: zerumbone exhibits moderate oral bioavailability with lipophilic character (log P ~3.5), enhanced by fat co-ingestion; flavonoid bioavailability is limited (~1-10% absorption) due to glycosylation requiring gut microbial deconjugation; saponins have poor systemic absorption (<5%) and act primarily at mucosal/surface interfaces. Most nutritional and phytochemical data derive from in vitro extraction studies; human pharmacokinetic data remain scarce. Traditional Pacific Islands use is predominantly topical (rhizome sap/juice), not dietary, limiting systemic nutritional relevance.
Zerumbone, the primary bioactive compound in Zingiber zerumbet, suppresses inflammatory responses by inhibiting nuclear factor-kappa B (NF-κB) translocation and reducing pro-inflammatory cytokine production including TNF-α and IL-1β. The plant's flavonoids kaempferol and quercetin scavenge free radicals through electron donation, while phenolic compounds demonstrate antimicrobial effects by disrupting bacterial cell membrane integrity. These mechanisms work synergistically to provide antioxidant, anti-inflammatory, and antimicrobial activities.
Current research on Zingiber zerumbet is limited to in vitro laboratory studies and animal models, with no published human clinical trials available. Laboratory studies have demonstrated antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans with minimum inhibitory concentrations ranging from 0.5-2.0 mg/ml. Animal studies using 50-100 mg/kg doses showed significant reduction in inflammatory markers and edema formation. The lack of human studies means optimal dosing, bioavailability, and clinical efficacy remain undetermined.
Safety data for Zingiber zerumbet is extremely limited with no established human dosage guidelines or comprehensive toxicity studies. As a member of the ginger family, it may theoretically increase bleeding risk when combined with anticoagulant medications like warfarin, though specific interactions have not been documented. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential uterine stimulant effects common to Zingiberaceae plants. Individuals with gallstones or bile duct obstruction should exercise caution as ginger-family plants may increase bile production.
